OpenLegislation

Regulation 69 Local dispute resolution before serving remedial notices or breach notices

United Kingdom

(1)

Subject to paragraph (3), before issuing a notice under regulation 70 or 71, F1NHS England must make every reasonable effort to communicate and co-operate with an NHS chemist (C) with a view to resolving any dispute between C and NHS England relating to C's compliance with C's terms of service.

(2)

Where an NHS pharmacist invites a Local Pharmaceutical Committee to participate in the attempts to resolve the dispute, NHS England must make every reasonable effort to communicate and co-operate with the Committee in its attempts to assist in resolving the dispute.

(3)

Paragraphs (1) and (2) do not apply where NHS England is satisfied—

(a)

the dispute relates to a matter that has already been the subject of dispute resolution between NHS England (or a Primary Care Trust) and C and there are no new issues of substance that justify delay in issuing a notice under regulation 70 or 71; F2...

F3(aa)

C is in breach of C’s obligation under regulation 68(1) in relation to the dispute; or

(b)

that it is appropriate to proceed immediately to issuing a notice under regulation 70 or 71—

(i)

because listed chemist premises are not, or have not been, open during core opening hours or supplementary opening hours without good cause F4, NHS England having made reasonable efforts to communicate with C with a view to establishing what the cause was,

(ii)

to protect the safety of any persons to whom C may provide pharmaceutical services, or

(iii)

to protect NHS England from material financial loss.

Annotations

Textual amendments

F1

Words in Regulations substituted (6.11.2023) by The Health and Care Act 2022 (Further Consequential Amendments) (No. 2) Regulations 2023 (S.I. 2023/1071), reg. 1(1), Sch. para. 1

F2

Word in reg. 69(3)(a) omitted (1.10.2026) by virtue of The National Health Service (Pharmaceutical and Local Pharmaceutical Services) (Amendment) (No. 2) Regulations 2026 (S.I. 2026/961), regs. 1(2), 8(2)(a)

F3

Reg. 69(3)(aa) inserted (1.10.2026) by The National Health Service (Pharmaceutical and Local Pharmaceutical Services) (Amendment) (No. 2) Regulations 2026 (S.I. 2026/961), regs. 1(2), 8(2)(b)

F4

Words in reg. 69(3)(b)(i) inserted (26.11.2018) by The National Health Service (Pharmaceutical Services, Charges and Prescribing) (Amendment) Regulations 2018 (S.I. 2018/1114), regs. 1(1), 3(2)